1. Peng DH, Kundu ST, Fradette JJ, Diao L, Tong P, Byers LA, Wang J, Canales JR, Villalobos PA, Mino B, Yang Y, Minelli R, Peoples MD, Bristow CA, Heffernan TP, Carugo A, Wistuba II, Gibbons DL. ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Science Translational Medicine. 2019 Mar 13;11(483): eaaq1238.
2. Wang Y, Zhang T, Guo L, Ren T, Yang Y. (2019). Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells. International Journal of Biochemistry [and] Cell Biology. 2019; 106:96-106.
3. Zhang T, Guo L, Creighton CJ, Lu Q, Gibbons DL, Yi ES, Deng B, Molina JR, Sun Z, Yang P, Yang Y. (2016). A genetic cell context-dependent role f[or] ZEB1 in lung cancer. Nature Communications. 2016 6:12231.
4. Chen Y, Terajima M, Yang Y, Sun L, Ahn YH, Pankova D, Puperi DS, Watanabe T, Kim MP, Blackmon SH, Rodriguez J, Liu H, Behrens C, Wistuba II, Minelli R, Scott KL, Sanchez-Adams J, Guilak F, Pati D, Thilaganathan N, Burns AR, Creighton CJ, Martinez ED, Zal T, Grande-Allen KJ, Yamauchi M, Kurie JM. Lysyl hydroxylase 2 induces a collagen cross-link switch in tum[or] stroma. Journal of Clinical Investigation. 2015 Mar 2;125(3):1147-62.
5. Yang Y, Ahn YH, Chen Y, Tan X, Guo L, Gibbons DL, Ungewiss C, Peng DH, Liu X, Lin SH, Thilaganathan N, Wistuba II, Rodriguez-Canales J, McLendon G, Creighton CJ, Kurie JM (2014). ZEB1 Sensitizes Lung Adenocarcinoma Cells to Metastasis Suppression by PI3K-Targeted Therapy. Journal of Clinical Investigation. 124(6): 2696-2708.
6. Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganthan N, Moreira DC, Creighton CJ, Gregory PA, Goodall GJ, Kurie JM. (2011). The Notch Lig[and] Jagged2 Promotes Lung Adenocarcinoma Metastasis Through a miR-200-dependent Pathway in Mice. Journal of Clinical Investigation. 121: 1373-1385.
7. Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Li H, Cai WW, Sato M, Minna JD, Wu H, Creighton C, Demayo FJ, Wistuba II, Kurie JM. (2008). Pten Inactivation Accelerates Oncogenic K-rasinitiated Tumorigenesis in a Mouse Model of Lung Cancer. Cancer Research. 68: 1119-1127.
8. Yang Y, Wislez M, Fujimoto N, Prudkin L, Izzo JG, Uno F, Ji L, Hanna AE, Langley RR, Liu D, Johnson FM, Wistuba I, Kurie JM. (2008). A selective small molecule inhibit[or] of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Molecular Cancer Therapeutics. 7(4):952-60.
9. Yang Y, Pan X, Lei W, Wang J, Shi J, Li F, Song JG. (2006). Regulation of transforming growth fact[or] β1-Induced apoptosis [and] epithelial to mesenchymal transition by protein kinase A [and] signal transducers [and] activators of tranion 3. Cancer Research. 66: 8617-8624
10. Yang Y, Pan X, Lei W, Wang J, Song JG. (2006). Transforming growth fact[or] β1 induces epithelial-to-mesenchymal transition [and] apoptosis via a cell cycle-dependent mechanism. Oncogene 25: 7235-7244.1.
